SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-007017
Filing Date
2023-10-10
Accepted
2023-10-10 08:30:24
Documents
15
Period of Report
2023-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acon_8k.htm   iXBRL 8-K 42862
2 COMMON STOCK PURCHASE AGREEMENT, DATED AS OF OCTOBER 9, 2023, BY AND BETWEEN WHI aclarion_ex1001.htm EX-10.01 223034
3 REGISTRATION RIGHTS AGREEMENT, DATED AS OF OCTOBER 9, 2023, BY AND BETWEEN WHITE aclarion_ex1002.htm EX-10.02 161232
  Complete submission text file 0001683168-23-007017.txt   725474

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE acon-20231009.xsd EX-101.SCH 3788
5 XBRL DEFINITION FILE acon-20231009_def.xml EX-101.DEF 26648
6 XBRL LABEL FILE acon-20231009_lab.xml EX-101.LAB 36765
7 XBRL PRESENTATION FILE acon-20231009_pre.xml EX-101.PRE 25272
9 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5290
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

IRS No.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 231315831
SIC: 8071 Services-Medical Laboratories